Status:
RECRUITING
Identification and Validation of Clinical Phenotypes in Staphylococcus Aureus Bacteremia and Their Association With Mortality and Development of Complicated Bacteremia
Lead Sponsor:
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Conditions:
Staphylococcus Aureus Bacteremia
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to determine retrospectively whether different patient clinical phenotypes (adults and children) develop Staphylococcus aureus bacteremia.The main questions it ...
Eligibility Criteria
Inclusion
- FOR STANDARD STUDY:
- Adults and children with clinically significant Staphylococcus aureus bacteremia (at least two classic systemic inflammatory response criteria: fever, tachycardia, tachypnea, lowered awareness, low blood pressure, leucocytosis/leucopenia, organ failure)
Exclusion
- Patients with non-clinically significant bacteremia.
- Death within 48 hours after detection of bacteremia for the inclusion of retrospective cases, life expectancy less than 48 hours for the inclusion of retrospective cases, life expectancy less than 48 hours for the inclusion of retrospective cases.
- Patients under palliative sedation at the time of bacteremia report.
- Polymicrobial bacteremia.
- FOR EXTENDED STUDY:
- Inclusion Criteria:
- Adults with clinically significant Staphylococcus aureus bacteremia included in the Standard Study
- Selected at random as one of the model phenotypes until completing recruitment (only HUVM and HUVV)
Key Trial Info
Start Date :
May 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2025
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06574399
Start Date
May 1 2023
End Date
March 31 2025
Last Update
August 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Virgen Macarena
Seville, Spain, 41009